.@abbvie has been accused of using a “patent thicket” to delay #biosimilars to its #Humira rheumatoid arthritis tre… https://t.co/OU0U9BI9eT
.@abbvie has been accused of using a “patent thicket” to delay #biosimilars to its #Humira rheumatoid arthritis tre… https://t.co/OU0U9BI9eT